.png){kind=icon}
.png){kind=icon}
Return
Therapies to Decrease Severe Respiratory Syncytial Virus Illness
.png){kind=icon}
PRE
AI
DOI：10.1001/jama.2024.7406.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
This JAMA Insights discusses the use of monoclonal antibodies or protein-based vaccines to help prevent severe RSV infection in infants, children, and older adults.
Keywords:
YOUNG-CHILDREN
PREVENTION
NIRSEVIMAB
PRETERM
RSV
Journal
J
IF:
55
Papers:
4.1W
Citations:
19.4W